Schedule 13G ownership disclosure

REVIVA PHARMACEUTCLS HLDGS INC COM

Security class unavailable · CUSIP: G8708A116

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.0600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001357550-20-000035
Form type
SC 13G
Filer
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK
CIK 1742927
Filed
Feb 13, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub